Cliff Asness’s ATRO Holdings & Trades

First Buy
Q2 2013
Duration Held
50 Quarters
Largest Add
Q3 2019
+181,980 Shares
Current Position
255,231 Shares
$11.64 M Value

Cliff Asness's ATRO Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 255,231 shares of Astronics Corporation (ATRO) worth $11.64 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.

Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ATRO, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2019, adding 181,980 shares. Largest reduction occurred in Q4 2020, reducing 124,501 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Astronics Corporation (ATRO) Holding Value Over Time

Track share changes against reported price movement

Quarterly Astronics Corporation (ATRO) Trades by Cliff Asness

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2013 +19,001 Add 0.00% 18,999 $18.69
Q3 2013 +81,470 Add 428.81% 100,469 $22.69
Q4 2013 +1,579 Add 1.57% 102,048 $27.95
Q1 2014 +4,015 Add 3.93% 106,063 $34.74
Q2 2014 -2,190 Reduce 2.06% 103,873 $30.93
Q3 2014 -45,601 Reduce 43.90% 58,272 $31.35
Q4 2014 -30,113 Reduce 51.68% 28,159 $36.36
Q1 2015 -8,163 Reduce 28.99% 19,996 $48.46
Q2 2015 +11,380 Add 56.91% 31,376 $46.60
Q3 2015 +42,502 Add 135.46% 73,878 $26.58
Q4 2015 -9,823 Reduce 13.30% 64,055 $30.79
Q1 2016 -43,153 Reduce 67.37% 20,902 $28.85
Q2 2016 -20,902 Sold Out 20,902 $0.00
Q1 2017 +9,828 New Buy 9,828 $27.57
Q2 2017 +26,417 Add 268.79% 36,245 $26.49
Q3 2017 +5,394 Add 14.88% 41,639 $25.87
Q4 2017 -32,322 Reduce 77.62% 9,317 $36.06
Q1 2018 -9,317 Sold Out 9,317 $0.00
Q4 2018 +8,503 New Buy 8,503 $30.46
Q1 2019 +1,674 Add 19.69% 10,177 $32.72
Q2 2019 +179,425 Add 1763.04% 189,602 $40.22
Q3 2019 +181,980 Add 95.98% 371,582 $29.38
Q4 2019 -90,107 Reduce 24.25% 281,475 $27.95
Q1 2020 -40,294 Reduce 14.32% 241,181 $9.18
Q2 2020 -31,924 Reduce 13.24% 209,257 $10.56
Q3 2020 -14,431 Reduce 6.90% 194,826 $7.72
Q4 2020 -124,501 Reduce 63.90% 70,325 $13.22
Q1 2021 -70,325 Sold Out 70,325 $0.00
Q2 2022 +39,627 New Buy 39,627 $10.17
Q3 2022 -39,627 Sold Out 39,627 $0.00
Q1 2023 +18,315 New Buy 18,315 $13.36
Q2 2023 -18,315 Sold Out 18,315 $0.00
Q3 2023 +10,704 New Buy 10,704 $15.86
Q4 2023 +17,305 Add 161.67% 28,009 $17.42
Q1 2024 +5,998 Add 21.41% 34,007 $19.04
Q2 2024 +3,786 Add 11.13% 37,793 $20.03
Q3 2024 +42,125 Add 111.46% 79,918 $19.48
Q4 2024 +13,317 Add 16.66% 93,235 $15.96
Q1 2025 +18,975 Add 20.35% 112,210 $24.17
Q2 2025 +125,808 Add 112.12% 238,018 $33.48
Q3 2025 +17,213 Add 7.23% 255,231 $45.61

Cliff Asness's Astronics Corporation Investment FAQs

Cliff Asness first purchased Astronics Corporation (ATRO) in Q2 2013, acquiring 18,999 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Astronics Corporation (ATRO) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness's largest addition to Astronics Corporation (ATRO) was in Q3 2019, adding 371,582 shares worth $10.92 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 255,231 shares of Astronics Corporation (ATRO), valued at approximately $11.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Astronics Corporation (ATRO) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness's peak holding in Astronics Corporation (ATRO) was 371,582 shares, as reported at the end of Q3 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.